Tumor weights were significantly higher in the pSUPER/RCAN2 group than in the pSUPER/non-silencing group (Figures 5f and g; pSUPER/RCAN2; 147 mg vs pSUPER/non-silencing; 31 mg, P=0.013). The gene discussed is RCAN2; the disease is neoplasm.